Published in J Thorac Cardiovasc Surg on July 01, 2011
Prevalence of deficient retro-aortic rim and its effects on outcomes in device closure of atrial septal defects. Pediatr Cardiol (2014) 0.85
Late erosion of an Amplatzer septal occluder device 6 years after placement. J Thorac Cardiovasc Surg (2011) 2.26
Comparative effectiveness of revascularization strategies. N Engl J Med (2012) 5.49
Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation (2007) 4.36
Early postoperative outcomes in a series of infants with hypoplastic left heart syndrome undergoing stage I palliation operation with either modified Blalock-Taussig shunt or right ventricle to pulmonary artery conduit. Pediatr Crit Care Med (2006) 2.77
Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study). Circulation (2012) 2.54
Successful linking of the Society of Thoracic Surgeons adult cardiac surgery database to Centers for Medicare and Medicaid Services Medicare data. Ann Thorac Surg (2010) 2.24
Differential case ascertainment in clinical registry versus administrative data and impact on outcomes assessment for pediatric cardiac operations. Ann Thorac Surg (2012) 2.22
Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database. J Thorac Cardiovasc Surg (2009) 2.17
Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg (2008) 2.04
From stem cells to viable autologous semilunar heart valve. Circulation (2005) 1.94
Aortico-left ventricular tunnel: 35-year experience. J Am Coll Cardiol (2004) 1.93
Report of the 2010 society of thoracic surgeons congenital heart surgery practice and manpower survey. Ann Thorac Surg (2011) 1.76
Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg (2008) 1.76
The influence of hemodilution on outcome after hypothermic cardiopulmonary bypass: results of a randomized trial in infants. J Thorac Cardiovasc Surg (2003) 1.69
Randomized trial of hematocrit 25% versus 35% during hypothermic cardiopulmonary bypass in infant heart surgery. J Thorac Cardiovasc Surg (2008) 1.69
Late pulmonary valve replacement in patients with pulmonary atresia and intact ventricular septum: a case-matched study. Ann Thorac Surg (2011) 1.60
Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. Am J Physiol Heart Circ Physiol (2004) 1.59
Successful linking of the Society of Thoracic Surgeons database to social security data to examine survival after cardiac operations. Ann Thorac Surg (2011) 1.58
The effect of hematocrit during hypothermic cardiopulmonary bypass in infant heart surgery: results from the combined Boston hematocrit trials. J Thorac Cardiovasc Surg (2008) 1.56
Total anomalous pulmonary venous connection: an analysis of current management strategies in a single institution. Ann Thorac Surg (2005) 1.55
Bioengineering challenges for heart valve tissue engineering. Annu Rev Biomed Eng (2009) 1.54
Congenital heart surgery databases around the world: do we need a global database? Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu (2010) 1.50
Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry. Circulation (2012) 1.50
Variation in outcomes for risk-stratified pediatric cardiac surgical operations: an analysis of the STS Congenital Heart Surgery Database. Ann Thorac Surg (2012) 1.46
Quality measures for congenital and pediatric cardiac surgery. World J Pediatr Congenit Heart Surg (2012) 1.45
Public reporting of healthcare data: a new frontier in quality improvement. Bull Am Coll Surg (2012) 1.45
A randomized, double-blind, placebo-controlled pilot trial of triiodothyronine in neonatal heart surgery. J Thorac Cardiovasc Surg (2005) 1.45
Modification to the Fontan procedure for the prophylaxis of intra-atrial reentrant tachycardia: short-term results of a prospective randomized blinded trial. J Thorac Cardiovasc Surg (2004) 1.44
Physician payment for 2007: a description of the process by which major changes in valuation of cardiothoracic surgical procedures occurred. Ann Thorac Surg (2007) 1.39
Right ventricle to pulmonary artery conduit augmentation compared with replacement in young children. Ann Thorac Surg (2009) 1.39
Surgical management of neonatal atrioventricular septal defect with aortic arch obstruction. Ann Thorac Surg (2013) 1.39
Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues. Biomaterials (2006) 1.38
The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue. Biomaterials (2005) 1.36
Regional low-flow perfusion versus circulatory arrest in neonates: one-year neurodevelopmental outcome. Ann Thorac Surg (2006) 1.36
A novel bioreactor for the dynamic flexural stimulation of tissue engineered heart valve biomaterials. Biomaterials (2003) 1.34
Early repair of hemitruncus: excellent early and late outcomes. J Thorac Cardiovasc Surg (2007) 1.33
Measurement of technical performance in congenital heart surgery: a pilot study. Ann Thorac Surg (2007) 1.27
Hypoplastic left heart syndrome with intact or highly restrictive atrial septum: surgical experience from a single center. Ann Thorac Surg (2007) 1.27
Guidelines for reporting mortality and morbidity after cardiac valve interventions. Eur J Cardiothorac Surg (2008) 1.26
Factors associated with prolonged recovery after the fontan operation. Circulation (2008) 1.25
Development of microfluidics as endothelial progenitor cell capture technology for cardiovascular tissue engineering and diagnostic medicine. FASEB J (2009) 1.23
Variation in congenital heart surgery costs across hospitals. Pediatrics (2014) 1.22
The role of organ level conditioning on the promotion of engineered heart valve tissue development in-vitro using mesenchymal stem cells. Biomaterials (2009) 1.19
Outcomes after bidirectional Glenn operation: Blalock-Taussig shunt versus right ventricle-to-pulmonary artery conduit. Ann Thorac Surg (2007) 1.17
Incorporation of the hepatic veins into the cavopulmonary circulation in patients with heterotaxy and pulmonary arteriovenous malformations after a Kawashima procedure. Ann Thorac Surg (2005) 1.14
Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling. J Heart Valve Dis (2002) 1.13
Heart valve regeneration. Adv Biochem Eng Biotechnol (2005) 1.13
Surgical outcome for patients with the mitral stenosis-aortic atresia variant of hypoplastic left heart syndrome. J Thorac Cardiovasc Surg (2007) 1.13
Long-term outcome of surgically treated patients with corrected transposition of the great arteries. J Thorac Cardiovasc Surg (2005) 1.12
Coarctectomy reduces neoaortic arch obstruction in hypoplastic left heart syndrome. J Thorac Cardiovasc Surg (2007) 1.12
Design and hydrodynamic evaluation of a novel pulsatile bioreactor for biologically active heart valves. Ann Biomed Eng (2004) 1.11
Guidance of engineered tissue collagen orientation by large-scale scaffold microstructures. J Biomech (2005) 1.09
Liver disease in the patient with Fontan circulation. Congenit Heart Dis (2011) 1.08
Cardiovascular outcomes after the arterial switch operation for D-transposition of the great arteries. Circulation (2012) 1.08
Analysis of surgical outcome in complex double-outlet right ventricle with heterotaxy syndrome or complete atrioventricular canal defect. Ann Thorac Surg (2006) 1.08
Causes of death after congenital heart surgery. Ann Thorac Surg (2007) 1.07
Socioeconomic position and graft failure in pediatric heart transplant recipients. Circ Heart Fail (2009) 1.06
Outcome after reconstruction of discontinuous pulmonary arteries. J Thorac Cardiovasc Surg (2002) 1.06
Transforming growth factor-beta1 modulates extracellular matrix production, proliferation, and apoptosis of endothelial progenitor cells in tissue-engineering scaffolds. Circulation (2006) 1.06
Improving results of the modified Fontan operation in patients with heterotaxy syndrome. Ann Thorac Surg (2002) 1.05
Functional collagen fiber architecture of the pulmonary heart valve cusp. Ann Thorac Surg (2009) 1.03
Long-term predictors of aortic root dilation and aortic regurgitation after arterial switch operation. Circulation (2004) 1.02
Long-term results of right ventricular outflow tract reconstruction in neonatal cardiac surgery: options and outcomes. J Thorac Cardiovasc Surg (2009) 1.02
In vivo monitoring of function of autologous engineered pulmonary valve. J Thorac Cardiovasc Surg (2010) 1.02
The rationale for incorporation of HIPAA compliant unique patient, surgeon, and hospital identifier fields in the STS database. Ann Thorac Surg (2008) 0.99
Valved homograft replacement of aneurysmal pulmonary arteries for severely symptomatic absent pulmonary valve syndrome. Ann Thorac Surg (2002) 0.98
Natural history of pulmonary atresia with intact ventricular septum and right-ventricle-dependent coronary circulation managed by the single-ventricle approach. Ann Thorac Surg (2006) 0.97
Electrospun PGS:PCL microfibers align human valvular interstitial cells and provide tunable scaffold anisotropy. Adv Healthc Mater (2014) 0.96
Dynamic rotational seeding and cell culture system for vascular tube formation. Tissue Eng (2003) 0.96
Cavopulmonary pathway modification in patients with heterotaxy and newly diagnosed or persistent pulmonary arteriovenous malformations after a modified Fontan operation. J Thorac Cardiovasc Surg (2010) 0.96
Measurement of technical performance in surgery for congenital heart disease: the stage I Norwood procedure. J Thorac Cardiovasc Surg (2008) 0.95
Regional structural and biomechanical alterations of the ovine main pulmonary artery during postnatal growth. J Biomech Eng (2013) 0.94
Aortic atresia or severe left ventricular outflow tract obstruction with ventricular septal defect: results of primary biventricular repair in neonates. Ann Thorac Surg (2006) 0.94
Myocardial immediate early gene activation after cardiopulmonary bypass with cardiac ischemia-reperfusion. Ann Thorac Surg (2002) 0.93
Effect of sex and race on outcome in patients undergoing congenital heart surgery: an analysis of the society of thoracic surgeons congenital heart surgery database. Ann Thorac Surg (2012) 0.93
Ebstein's malformation of the tricuspid valve: short-term outcomes of the "cone procedure" versus conventional surgery. Congenit Heart Dis (2011) 0.93
Risk factors for readmission after neonatal cardiac surgery. Ann Thorac Surg (2004) 0.92
Endothelial progenitor cells as a sole source for ex vivo seeding of tissue-engineered heart valves. Tissue Eng Part A (2010) 0.92
Arterial switch operation with a single coronary artery. J Thorac Cardiovasc Surg (2002) 0.91
Intravital molecular imaging of small-diameter tissue-engineered vascular grafts in mice: a feasibility study. Tissue Eng Part C Methods (2010) 0.89
Thoracic Surgery Directors Association Award. Bone marrow as a cell source for tissue engineering heart valves. Ann Thorac Surg (2003) 0.88
Cerebral oximetry during infant cardiac surgery: evaluation and relationship to early postoperative outcome. Anesth Analg (2009) 0.87
Linking the congenital heart surgery databases of the Society of Thoracic Surgeons and the Congenital Heart Surgeons' Society: part 1--rationale and methodology. World J Pediatr Congenit Heart Surg (2014) 0.87
Outcome after Fontan failure and takedown to an intermediate palliative circulation. Ann Thorac Surg (2007) 0.86
Creation of a brachial arteriovenous fistula for treatment of pulmonary arteriovenous malformations after cavopulmonary anastomosis. Ann Thorac Surg (2005) 0.85
Optimal elastomeric scaffold leaflet shape for pulmonary heart valve leaflet replacement. J Biomech (2013) 0.85
What is the clinical utility of routine cardiac catheterization before a Fontan operation? Pediatr Cardiol (2010) 0.85
Endothelial progenitor and mesenchymal stem cell-derived cells persist in tissue-engineered patch in vivo: application of green and red fluorescent protein-expressing retroviral vector. Tissue Eng (2007) 0.84
Predictors of outcome of arterial switch operation for complex D-transposition. Ann Thorac Surg (2008) 0.84
Staged repair of tetralogy of Fallot and diminutive pulmonary arteries with a fenestrated ventricular septal defect patch. J Thorac Cardiovasc Surg (2003) 0.83
Superparamagnetic iron oxide (SPIO) labeling efficiency and subsequent MRI tracking of native cell populations pertinent to pulmonary heart valve tissue engineering studies. NMR Biomed (2011) 0.83
Pulmonary artery conduit in vivo dimensional requirements in a growing ovine model: comparisons with the ascending aorta. J Heart Valve Dis (2013) 0.83
Younger age and valve oversizing are predictors of structural valve deterioration after pulmonary valve replacement in patients with tetralogy of Fallot. J Thorac Cardiovasc Surg (2011) 0.83
Survival and clinical course at Fontan after stage one palliation with either a modified Blalock-Taussig shunt or a right ventricle to pulmonary artery conduit. J Am Coll Cardiol (2008) 0.83
Early postoperative severity of illness predicts outcomes after the stage I Norwood procedure. Ann Thorac Surg (2011) 0.83
Application of tissue-engineering principles toward the development of a semilunar heart valve substitute. Tissue Eng (2005) 0.82
Intermediate outcomes of atrioventricular valvuloplasty in lateral tunnel Fontan patients. J Heart Valve Dis (2004) 0.82
Technical performance scores in congenital cardiac operations: a quality assessment initiative. Ann Thorac Surg (2012) 0.81
Apical ventricular septal defects: follow-up concerning anatomic and surgical considerations. Ann Thorac Surg (2002) 0.81
Estimated in vivo postnatal surface growth patterns of the ovine main pulmonary artery and ascending aorta. J Biomech Eng (2013) 0.81